This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Pediatrics, Other  • Psychiatry  • Child Psychiatry  • Alert me on articles by topic  Social Bookmarking   What's this?

What Does the Increase Mean?

Arch Pediatr Adolesc Med. 2004;158:829-830.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The 1990s may become known as the decade of psychotropic medication use in children. This includes, to differing degrees, several classes of drugs: stimulants, antidepressants (especially selective serotonin reuptake inhibitors [SSRIs]), antianxiety agents, and antipsychotics. Evidence of increasing use among children of various ages has been mounting for years. Previous studies have demonstrated higher rates of psychoactive prescription use in adolescents,¹ preschoolers,² and those in between.³ These medications have been prescribed for attention-deficit/hyperactivity disorder (ADHD), conduct disorder, depression, and various other behavioral, mental, or learning disorders.

The article by Cooper et al⁴ contributes to this accumulating evidence by examining the changes in prescription rates of one class of medications given to children and adolescents (aged 2 to 18 years) in a large specific population (TennCare). The authors focus on new users of atypical antipsychotics in the Tennessee Medicaid population. By new users (perhaps better termed new uses), they designate . . . [Full Text of this Article]

Peter Conrad, PhD

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

New Users of Antipsychotic Medications Among Children Enrolled in TennCare
William O. Cooper, Gerald B. Hickson, Catherine Fuchs, Patrick G. Arbogast, and Wayne A. Ray
Arch Pediatr Adolesc Med. 2004;158(8):753-759.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Making All the Children Above Average: Ethical and Regulatory Concerns for Pediatricians in Pediatric Enhancement Research
Berg et al.
CLIN PEDIATR 2009;48:472-480.
ABSTRACT  

Psychotropic Medication Use in Pediatric Patients With Cancer
Pao et al.
Arch Pediatr Adolesc Med 2006;160:818-822.
ABSTRACT | FULL TEXT